Tag: CSL Behring

Global biotech company CSL has opened a new $900 million Plasma Fractionation Facility in Victoria, bolstering the future of plasma manufacturing in Australia. 

Nightingale Security, the world’s leading autonomous drone security company, is continuing to build on its blue chip client base by signing a slew of major new accounts, including CSL Limited’s biopharma manufacturing company CSL Behring, multinational automotive manufacturer General Motors, and Haliburton, one the world's largest providers of products and services for the ever-evolving needs of the Energy industry.

CSL Limited has wrapped up the acquisition of uniQure’s etranacogene dezaparvovec, a novel gene therapy for the treatment of haemophilia B. Under the agreement, CSL...

CSL has been given the nod by the Therapeutic Goods Administration (TGA) to commence the manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia. TGA’s...

Media Release Bosch Australia’s Manufacturing Solutions division (BAMS) has been awarded a contract to create a high-tech automatic materials handling line for CSL Behring (Australia),...

CSL Behring, the major operating arm of the CSL Group, has agreed to acquire US Biotechnology company Calimmune, Inc. for an upfront payment of...

Australian biotech firm CSL has agreed to acquire an 80% stake in China’s plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biologics (Ruide) in...

The Australian Labor Government has recognised exemplary companies and individuals in the Victorian manufacturing industry at the 2016 Manufacturing Hall of Fame gala Dinner. Broadmeadows-based...

AMWU members at CSL Behring, who make vital blood plasma products and maintain factory equipment, staged a 4-hour work stoppage last Friday in response...